Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine
Clinical trial NCT01820559 · COMPLETED
Trial details
- NCT number
- NCT01820559
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-06-01
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.